Enveric Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ENVB, updated each market day.
ENVB AI Sentiment
AI sees no strong directional signal for Enveric Biosciences, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Enveric Biosciences, Inc. Common Stock
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Sector
Exchange
Market Cap
$3,850,571
Cap Tier
Employees
6
Headquarters
CAMBRIDGE, MA
Listed Since
Aug. 24, 1995
Website
ENVB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ENVB Volatility
Enveric Biosciences, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
